PatoGen AS establishes laboratories for research and development within aquaculture. It offers the following products: PatoSafe, SmoltTimer, and LiceAdvisor. The company is headquartered in Alesund, Norway.

Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY.

Kangstem Biotech develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Part of Sysmex Corp., International Reagents Corp. is a company headquartered in Kobe-shi, Japan, that manufactures reagents. On April 01, 2002 Sysmex Corp. acquired International Reagents Corp.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. By targeting this clinically proven therapeutic target with novel small molecules, we are progressing with new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications. PHA121, Pharvaris’ lead drug candidate, is a novel and potent small-molecule bradykinin B2 receptor antagonist currently under Phase 1 clinical study. The co-founders of Pharvaris include an inventor of icatibant and the leadership from Jerini AG that developed icatibant for the treatment of HAE, now sold by Takeda under the brand name Firazyr®.

Hunan Jinsui Rice Co., Ltd., established on 1997-05-07, Business scope includes licensed projects:Grain Processed Food Production;food sales;feed production;food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Grain Purchase;grain sales;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Loading and unloading;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Purchase of agricultural means of production,use;Purchase of primary agricultural products;Sales of agricultural and sideline products;Animal Husbandry and Fishery Feed Sales;Primary processing of edible agricultural products;Primary processing of non-edible agricultural products;Agricultural production hosting service;Agricultural Machinery Service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Alexera AB owns and manages healthcare related discoveries and inventions. The company is headquartered in Gothenburg, Sweden.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Yangling Yizhinong Microbial Engineering Technology Research Institute Co., Ltd., established on 2011-12-05, The scope of business includes farming,Agricultural product processing industry,Production of microbial preparations for feed additives and environmental pollution remediation,Sales(except pesticides);Microbial preparations,R&D and transfer of process and equipment;Provide relevant technical consultation and promotion application services;Self-support import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Anhui Kangshengyuan Ecological Agriculture Co., Ltd., established on 2006-02-20, Business scope includes licensed projects:Production of tea products;food production;food sales;Food Internet Sales;Packaging and decoration printing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Agricultural Science Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;tea planting;fruit planting;Nut planting;grain planting;vegetable planting;Oily Fruit Planting;Chinese herbal medicine planting;tree planting business;Edible mushroom cultivation;Horticultural Products Planting;Purchase of primary agricultural products;Primary processing of edible agricultural products;Primary processing of non-edible agricultural products;Sales of agricultural and sideline products;internet sales(Except for products that require a license for sale);Leisure and sightseeing activities(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

Valenta Pharmaceuticals JSC manufactures and distributes pharmaceuticals. The firm engages in development, production, and market launch of prescription and OTC medicines for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, and urology. The company was founded in 1997 and is headquartered in Moscow, Russia.

Zhengqi Food Science and Technology Research Institute (Guangzhou) Co., Ltd., established on 2016-10-17, Business scope includes retail of cosmetics and hygiene products;Cosmetics Retail;Research on water treatment equipment,to develop;Wholesale food additives;Wholesale of cosmetics and hygiene products;Cosmetics Wholesale;Food Additives Retail;Agricultural Science Research and Experimental Development;Acupuncture Medicine Research;Medical Research and Experimental Development;Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Stem Cell Technology Research,to develop;Research on Radiation Protection Equipment,to develop,design;Food Science and Technology Research Services;Energy Technology Research,Technology Development Services;Technical Research on Biomass Energy,to develop;Research on Biomass Pyrolysis Technology,to develop,Technical Services